AVAILABILITY OF REIMBURSABLE ONCOLOGY MEDICINES IN EU MEMBER STATES
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: CACHIA, Alexandra (University of Malta, Zabbar, Malta)
- Co-author(s): Anthony Serracino-Inglott
Oncology medicines are among the costliest of medicines. Most European Union (EU) member states make decisions to reimburse oncology medicines based on positive lists (lists of reimbursable medicines).
Positive lists were obtained for EU member states when available. Oncology medicines were identified based on their ATC code. ATC codes L01 and L02,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.